The Latin American and Caribbean Medicines Agency (AMLAC) may provide improved consistency in regulation, but what does that mean for access?

In April 2023, medical regulatory authorities of Colombia (INVIMA), Cuba (CECMED), and Mexico (COFEPRIS) signed the “Declaration of Acapulco” for the creation of the Latin American and Caribbean Medicines and Medical Devices Regulatory Agency (AMLAC)